Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 05  •  04:00PM ET
37.69
Dollar change
-0.22
Percentage change
-0.58
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y43.90% Total Holdings36 Perf Week-0.58%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- AUM93.93M Perf Month19.88%
Fund Family Bond Type Tagsinnovation Return% 5Y- NAV/sh Perf Quarter29.83%
Index- Average Maturity Tagshealthcare Return% 10Y 52W High37.99 -0.79% Perf Half Y63.51%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low18.78 100.69% Perf YTD61.13%
Active/Passive Quant Type Tagsmedical Flows% 1M4.43% Volatility1.17% 1.77% Perf Year43.59%
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M6.28% ATR (14)0.77 Perf 3Y-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD13.65% RSI (14)68.26 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta1.35 Perf 10Y-
Expense0.54% Growth/Value SMA206.37% Flows% 3Y Rel Volume2.54 Prev Close37.91
Inverse/Leveraged Market Cap SMA5015.61% Flows% 5Y Avg Volume4.30K Price37.69
IPOOct 31, 2024 Option/ShortNo / No SMA20041.99% Trades Volume10,924 Change-0.58%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.